ASHM, May 2024 Contraception Essentials: Navigating a Consultation is a video resource designed to support clinicians in their contraceptive consultations. The video guides clinicians to utilise ASHM’s Decision Making in Contraception: Consultation Essential resource to conduct patient-centred and evidence-based contraceptive consultations. Through the demonstration consultation, viewers will...
IUD saving fertility for women with cancer
University of Queensland, March 2021 A common intrauterine device (IUD) could help preserve fertility and reduce the need for hysterectomies for women suffering endometrial cancer, according to University of Queensland research. UQ’s Professor Andreas Obermair, from the Queensland Centre for Gynaecological Cancer Research, said his team had just completed the feMMe study – a phase II randomised...
Changes in use of hormonal long‐acting reversible contraceptive methods in Australia 2006 – 2018
Changes in use of hormonal long‐acting reversible contraceptive methods in Australia between 2006 and 2018: A population‐based study Luke E. Grzeskowiak, Helen Calabretto, Natalie Amos, Danielle Mazza, Jenni Ilomaki ANZJOG First published: 23 October 2020, Abstract: Background Long‐acting reversible contraceptives (LARCs) are promoted internationally as a key strategy for reducing unintended...
Shortage of norethisterone-containing pills in Australia: Advice for GPs
July/August 2020 The Therapeutic Goods Administration (TGA) advises: Consumers and health professionals are advised that there is a shortage of oral contraceptive pills containing the combination ethinylestradiol and norethisterone. The affected products are: Brevinor – norethisterone 0.5 mg and ethinylestradiol 35 micrograms Norimin – norethisterone 0.5 mg and ethinylestradiol 35...
Clinical Education Forum Recording: Contraception Update
SHINE SA, November 2018 Clinicians: SHINE SA is pleased to present the following Clinical Forum by Dr Amy Moten on the topic of Contraception. This recording is available free of charge, and access is limited to three months only. This forum covers emergency contraception and new formulations of the Pill. 3 Category 2 RACGP Points can be awarded on completion of the forum. Recording length: 1...
SHINE SA Media Release: Response to the call to ban Diane-35
SHINE SA, issued 13th December 2017 SHINE SA believes everyone should have access to contraceptive choices, and that decisions about contraception are best made in conjunction with a healthcare professional. Cyproterone acetate pills, commonly known as Diane-35 appear to be associated with a higher risk of deep venous thrombosis (DVT) than levonorgestrel (LNG) containing pills, although the...